A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Advanced Cancer · Cachexia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China
Contact: Study coordinator (Wu DaWei) · wumingshi-117@163.com · +86 10 8778 8495
Contact: Principal Investigator (Ning Li)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors

Advanced Cancer

Abroad (travel likely)RecruitingPHASE1

Beijing, China · Fuzhou, China

Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors

Solid Tumor · Advanced Cancer

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China · Guiyang, China